Scancell
Clinical-stage immunotherapy developer for difficult-to-treat cancers, using Immunobody and Moditope platforms
Highlights
- New on EvolcAdded 2026-10-28
About Scancell
Scancell develops active immunotherapies for cancer, built on its proprietary Immunobody® and Moditope® platforms. Its lead product, iSCIB1+, is an Immunobody® DNA active immunotherapy studied in advanced melanoma, and the lead Moditope® peptide immunotherapy, Modi-1, is in a Phase 2 study across solid tumours. A wholly owned subsidiary, Glymab Therapeutics Ltd., develops GlyMab® and AvidiMab® antibody technologies; two GlyMab® antibodies have been licensed to Genmab.
The company is a clinical-stage biotech that funds its work through partnering deals and capital raises, and it lists partnerships with GenMab, CVLP, PharmaJet and the University of Nottingham.
Scancell Limited is incorporated in the United Kingdom, where its main operations are located, and is headquartered in Oxford. It was founded in 1996 and is listed on the London Stock Exchange (LSE:SCLP). Its website lists a leadership team and board that includes clinical advisers from institutions in the United States, United Kingdom, Italy, Netherlands and Germany.
Product: Active immunotherapies (Immunobody® DNA and Moditope® peptide platforms) for cancer, including the lead candidate iSCIB1+.
Jobs at Scancell
More biotech & pharma companies
Scripta Therapeutics
Drug discovery platform using transcription factor mapping and AI models to find neurodegenerative disease therapiesYoung companyNew on EvolcSisaf
RNA drug-delivery platform licensed to pharma partners, with a research reagent for labs plannedNew on EvolcSitala Bio
Develops medicines targeting harmful inflammation for patients with neurodegenerative and inflammatory diseasesNew on EvolcSmartway Pharmaceuticals
Pharmaceutical wholesaling and specialist medicine supply for healthcare providers, pharmaceutical companies and aid organizationsNew on EvolcSolasta Bio
Develops peptide-based precision insecticides for growers and agricultural businesses seeking crop protectionNew on EvolcSPT Labtech
Lab automation instruments for liquid handling and sample management, sold to life science research laboratories
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- CookieScript
- Google Analytics 4
- Google reCAPTCHA
- WooCommerce
- WordPress
- jQuery
- nginx